Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Delahousse

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 26, 2002
Comparative evaluation of five different methods for the measurement of plasma factor II levels in carriers of the 20210A prothrombin variantB Delahousse, M Gilbert, F Nicham, et al.
Thrombosis Research|March 1, 1988
Levels and plasma distribution of free and C4b-BP-bound protein S in human fetuses and full-term newbornsP Moalic, Y Gruel, G Body, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1998
Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assaysB Delahousse, S Iochmann, C Pouplard, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 7, 2001
Increased plasma fibrinolysis and tissue-type plasminogen activator/tissue-type plasminogen activator inhibitor ratios after ethanol withdrawal in chronic alcoholicsB Delahousse, F Maillot, I Gabriel, et al.
American Journal of Veterinary Research|January 1, 1989
Hemostasis development in the lamb fetus and neonateP Moalic, Y Gruel, P Foloppe, et al.
Blood|August 1, 1996
Evolution of blood coagulation activators and inhibitors in the healthy human fetusP Reverdiau-Moalic, B Delahousse, G Body, et al.
American Journal of Clinical Pathology|May 7, 1999
Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopeniaC Pouplard, J Amiral, J Y Borg, et al.
British Journal of Haematology|December 31, 1997
Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodiumC Pouplard, J Amiral, J Y Borg, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1985
Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216)J Leroy, M H Leclerc, B Delahousse, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2002
A blinded in vitro study with Refacto mock plasma samples: similar FVIII results between the chromogenic assay and a one-stage assay when using a higher cephalin dilutionC Caron, M-D Dautzenberg, B Delahousse, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 26, 2002
Comparative evaluation of five different methods for the measurement of plasma factor II levels in carriers of the 20210A prothrombin variantB Delahousse, M Gilbert, F Nicham, et al.
Thrombosis Research|March 1, 1988
Levels and plasma distribution of free and C4b-BP-bound protein S in human fetuses and full-term newbornsP Moalic, Y Gruel, G Body, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1998
Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assaysB Delahousse, S Iochmann, C Pouplard, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 7, 2001
Increased plasma fibrinolysis and tissue-type plasminogen activator/tissue-type plasminogen activator inhibitor ratios after ethanol withdrawal in chronic alcoholicsB Delahousse, F Maillot, I Gabriel, et al.
American Journal of Veterinary Research|January 1, 1989
Hemostasis development in the lamb fetus and neonateP Moalic, Y Gruel, P Foloppe, et al.
Blood|August 1, 1996
Evolution of blood coagulation activators and inhibitors in the healthy human fetusP Reverdiau-Moalic, B Delahousse, G Body, et al.
American Journal of Clinical Pathology|May 7, 1999
Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopeniaC Pouplard, J Amiral, J Y Borg, et al.
British Journal of Haematology|December 31, 1997
Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodiumC Pouplard, J Amiral, J Y Borg, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1985
Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216)J Leroy, M H Leclerc, B Delahousse, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2002
A blinded in vitro study with Refacto mock plasma samples: similar FVIII results between the chromogenic assay and a one-stage assay when using a higher cephalin dilutionC Caron, M-D Dautzenberg, B Delahousse, et al.
Pageof 2